Stephen Kanes

Chief Medical Officer, Sage Therapeutics, Inc.

Companies

Centessa Pharmaceuticals plcChief Medical Officer Jan 16, 2025 to now¹
Sage Therapeutics, Inc.Chief Medical Officer Jul 17, 2014 to Oct 21, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Sage Therapeutics, Inc.13,471 shares³Oct 19, 2021
Centessa Pharmaceuticals plc0 shares⁴Jun 24, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 24, 2026Returned to company 120,000 shares of Centessa Pharmaceuticals plc⁴
Feb 2, 2026Granted 120,000 shares of Centessa Pharmaceuticals plc⁵
Oct 19, 2021Shares withheld for tax 1,120 shares at $40.29 of Sage Therapeutics, Inc.³
Oct 19, 2021Granted 3,800 shares of Sage Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCentessa Pharmaceuticals plc, Chief Medical Officer
2
SEC EDGARSage Therapeutics, Inc., Chief Medical Officer
3
SEC EDGARSage Therapeutics, Inc. shares after the filing of Oct 19, 2021
4
SEC EDGARCentessa Pharmaceuticals plc shares after the filing of Jun 24, 2026
5
SEC EDGARForm 4 filed Feb 3, 2026